Scholar Rock Holding Corp 10-Q for FY2026 Q3
Scholar Rock Holding Corp (SRRK)
10-Q
2026-11-10
For: 2026-09-30
View Original
Added on
November 10, 2026
About this 10-Q
Scholar Rock Holding Corp filed this 10-Q on November 10, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Scholar Rock Holding Corp launched ISEMBYLD after September 11, 2026 FDA approval, generating $0.6 million revenue for nine months ended September 30, 2026. It agreed to sell a priority review voucher to BioNTech US Inc. for $205.0 million. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $570K
- compared with $0 a year earlier
- Net loss
- $107.24M
- compared with a net loss of $102.22M a year earlier
- Diluted EPS
- -$0.81
- compared with -$0.90 a year earlier